Your browser doesn't support javascript.
loading
[Analysis of HIV genotypic drug resistance among pediatric HIV/AIDS cases with virological failure after free antiretroviral therapy in Yunnan province].
Zhong, Min; Yang, Shaomin; Yang, Bihui; Liu, Jiafa; Li, Jianjian; Lou, Jincheng; Li, Huiqin.
Afiliação
  • Zhong M; Yunnan Provincial Hospital of Infectious Disease, AIDS Care Center Laboratory, Kunming 650301, China.
  • Yang S; Yunnan Provincial Hospital of Infectious Disease, AIDS Care Center Laboratory, Kunming 650301, China. Email: smy57@sina.com.
  • Yang B; Yunnan Provincial Hospital of Infectious Disease, AIDS Care Center Laboratory, Kunming 650301, China.
  • Liu J; Yunnan Provincial Hospital of Infectious Disease, AIDS Care Center Laboratory, Kunming 650301, China.
  • Li J; Yunnan Provincial Hospital of Infectious Disease, AIDS Care Center Laboratory, Kunming 650301, China.
  • Lou J; Yunnan Provincial Hospital of Infectious Disease, AIDS Care Center Laboratory, Kunming 650301, China.
  • Li H; Yunnan Provincial Hospital of Infectious Disease, AIDS Care Center Laboratory, Kunming 650301, China.
Zhonghua Yi Xue Za Zhi ; 94(12): 884-8, 2014 Apr 01.
Article em Zh | MEDLINE | ID: mdl-24854905
OBJECTIVE: To assess the prevalence and the characteristics of HIV-1 drug-resistance in pediatric HIV/AIDS cases with virological failure after free antiretroviral therapy in Yunnan Province. METHODS: The data of clinical test and laboratory detection about free antiretroviral therapy in pediatric HIV/AIDS cases from 2005 to 2012 were collected. Then the detection of HIV genotypical drug resistance was performed for the plasmas samples whose viral load were over 1 000 copies/ml after the duration of antiretroviral therapy beyond 6 months. The prevalence and the characteristics of HIV-1 drug resistance were obtained for subsequent analysis. RESULTS: A total of 73 cases suffered virological failure among 729 cases while 53 cases exhibited the resistance for antiretroviral drugs.So the resistance ratio was 72.6% (53/73) and the general resistance ratio 7.3% (53/729). The prevalent mutations associated with drug resistance were M184V/I, K103N, T215F/Y, G190A, Y181C and K101E at the frequencies of 52.1% (38/73), 30.1% (22/73), 21.9% (16/73), 20.5% (15/73), 15.1% (11/73) and 12.3% (9/73) respectively. The percentage of resistance to NVP, 3TC, EFV, D4T, AZT and ABC was 61.6% (45/73) , 54.8% (40/73) , 47.9% (35/73) , 13.7% (10/73) , 12.3% (9/73) and 5.5% (4/73) respectively. One case developed intermediate resistance to LPV/r. CONCLUSIONS: The main causes of virological failure is drug resistance.So reducing the incidence and spread of HIV drug resistance is of vital importance in modern era of resource scarcity.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome da Imunodeficiência Adquirida / HIV-1 / Farmacorresistência Viral Tipo de estudo: Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: Zh Ano de publicação: 2014 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome da Imunodeficiência Adquirida / HIV-1 / Farmacorresistência Viral Tipo de estudo: Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: Zh Ano de publicação: 2014 Tipo de documento: Article